Evidence map›Paper›PMID 33399537›Full record

ArticleeLife2021

Checkpoint inhibition of origin firing prevents inappropriate replication outside of S-phase.

Mark C Johnson, Geylani Can, Miguel Monteiro Santos, Diana Alexander, Philip Zegerman

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mark C JohnsonWellcome Trust/Cancer Research United Kingdom Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-6136-7055
Geylani CanWellcome Trust/Cancer Research United Kingdom Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-1716-7830
Miguel Monteiro SantosWellcome Trust/Cancer Research United Kingdom Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-5594-2682
Diana AlexanderWellcome Trust/Cancer Research United Kingdom Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-7785-3170
Philip ZegermanWellcome Trust/Cancer Research United Kingdom Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-5707-1083
The Gurdon Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M011194/1Cancer Research UK C15873/A12700Cancer Research UK C6946/A14492Wellcome Trust 092096Wellcome Trust 107056/Z/15/Z
6 · The paper itself

Abstract

Checkpoints maintain the order of cell cycle events during DNA damage or incomplete replication. How the checkpoint response is tailored to different phases of the cell cycle remains poorly understood. The S-phase checkpoint for example results in the slowing of replication, which in budding yeast occurs by Rad53-dependent inhibition of the initiation factors Sld3 and Dbf4. Despite this, we show here that Rad53 phosphorylates both of these substrates throughout the cell cycle at the same sites as in S-phase, suggesting roles for this pathway beyond S-phase. Indeed, we show that Rad53-dependent inhibition of Sld3 and Dbf4 limits re-replication in G2/M, preventing gene amplification. In addition, we show that inhibition of Sld3 and Dbf4 in G1 prevents premature initiation at all origins at the G1/S transition. This study redefines the scope of the 'S-phase checkpoint' with implications for understanding checkpoint function in cancers that lack cell cycle controls.

Indexed as

Cell CycleCell Cycle ProteinsCheckpoint Kinase 2Saccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsS PhaseCell Cycle ProteinsCheckpoint Kinase 2RAD53 protein, S cerevisiaeSaccharomyces cerevisiae Proteinscell cyclecheckpointschromosomesgene expressiongenome stabilityRad53replicationS. cerevisiaeS-phase

Identifiers

PMID33399537
PMCPMC7806266
OpenAlexW3120078987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.